Skip to main content

Table 1 Critical trauma patient’s characteristics (n = 23)

From: Argininemia and plasma arginine bioavailability – predictive factors of mortality in the severe trauma patients?

 

n (%) or mean ± SD

Male gender

18 (78.3)

Age (years-old)

48.8 ± 17.8 (21–82)

Charlson’s comorbidity index

0.78 ± 1.98 (0–8)

Primary admission

18 (78.3)

APACHE II

19.4 ± 5.5 (10–32)

SAPS II

41.3 ± 12.2 (20–78)

SOFA

6.9 ± 3.2 (2–10)

Shock index

0.82 ± 0.25 (0.31–1.4)

Abbreviated Injury Scale

15.4 ± 4.9 (10–25)

Injury Severity Score

47.9 ± 18.5 (27–75)

Revised Trauma Score

5.9 ± 1.3 (3.6–7.6)

Invasive ventilation

23 (100)

Renal replacement therapy

0 (0)

Amines perfusion

16 (69.6)

Erythrocytes transfusion

14 (60.9)

Nutritional support

 Enteral/Parenteral

23 (100)/1 (4.3)

 Glutamine supplementationa

1 (4.3)

 Surgical proceduresb

14 (65.2)

Mortality rate

 ICU/Hospital/Global

4 (17.4)/6 (26.1)/10 (43.5)

 Health care-associated infections rate

20 (87)

 Ventilation support (days)

12.7 ± 7.8 (2–27)

Length of stay (days)

 ICU/Hospital (days)

13.9 ± 9.1 (3–52)/29.4 ± 21.9 (5–95)

 Follow-up (months)

7.4 ± 3.1 (2.3–12.2)

 Actuarial survival (days)

229.2 ± 32.9 (95 % CI 164.7–293.8)

 Karnofsky’s index

69 ± 17.3 (40–90)

  1. Data presented as number (%) or mean ± standard deviation
  2. APACHE II acute physiology and chronic health evaluation II, ICU intensive care unit, SAPS II simplified acute physiology score II, SD standard deviation, SOFA sequential organ failure assessment
  3. aGlutamine was administered after the third day in the intensive care unit
  4. bOperations before intensive care unit admission (n = 4); operations after the third day in intensive care unit (n = 5)